Kaplan-Meier survival curves showing survival after ruxolitinib discontinuation. Comparison of survival after discontinuation by platelet counts at (A) baseline and (B) follow-up. (C) Comparison of survival after ruxolitinib discontinuation in those with and without clonal evolution. Cum, cumulative; FU, follow-up; HR, hazard ratio.